AAV6. ARKct cardiac gene therapy ameliorates cardiac function and normalizes the catecholaminergic axis in a clinically relevant large animal heart failure model

Does AAV6.ARKct cardiac gene therapy improve cardiac function in a post-MI pig HF model?

AAV6.ARKct gene therapy demonstrates therapeutic potential for heart failure by improving cardiac function in a clinically relevant large animal model.